Stem cells and Bronchopulmonary Dysplasia - The five questions: Which cells, when, in which dose, to which patients via which route?

Martin Mueller*, Boris W. Kramer

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)54-59
Number of pages6
JournalPaediatric Respiratory Reviews
Volume24
DOIs
Publication statusPublished - Sep 2017

Keywords

  • Bronchopulmonary dysplasia
  • mesenchymal stem cell transplantation
  • paracrine immunomodulation
  • physiologic actions
  • outcomes
  • HUMAN UMBILICAL-CORD
  • INDUCED LUNG INJURY
  • MESENCHYMAL PROGENITOR CELLS
  • PRETERM BIRTH
  • STROMAL CELLS
  • HUMAN PLACENTA
  • LONG-TERM
  • THERAPY
  • MICE
  • DIFFERENTIATION

Cite this